Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

441
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
441
Disorders of Hemostasis01:24

Disorders of Hemostasis

673
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
673
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

3.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

585
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
585
Structure and Function of Platelets01:18

Structure and Function of Platelets

931
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
931
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

3.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study on the influence mechanism of environmental perception on physical health status-with lifestyle as the mediating variable.

Frontiers in public health·2026
Same author

TET3 facilitates bladder cancer progression through targeted modulation of stemness pathways.

Medical oncology (Northwood, London, England)·2025
Same author

HMGB1-Platelet Interactions: Mechanisms and Targeted Therapy Strategies.

Thrombosis and haemostasis·2025
Same author

Design, synthesis and FXR partial agonistic activity of anthranilic acid derivatives bearing aryloxy moiety as therapeutic agents for metabolic dysfunction-associated steatohepatitis.

Bioorganic chemistry·2024
Same author

Role of Platelets and Their Interaction with Immune Cells in Venous Thromboembolism.

Seminars in thrombosis and hemostasis·2024
Same author

Mechanism of Bile Acid in Regulating Platelet Function and Thrombotic Diseases.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2024

Related Experiment Video

Updated: May 21, 2025

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K

Platelet Disorders and Medication Strategies.

Zhao Zhang1, Xianghui Zhou1, Xiyuan Fang1

  • 1Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.

Thrombosis and Haemostasis
|March 19, 2025
PubMed
Summary

This review explores platelet production, covering hematopoietic stem cells and megakaryocytes. It summarizes platelet disorders like thrombocytopenia and thrombocytosis and their treatment strategies.

More Related Videos

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.5K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

738

Related Experiment Videos

Last Updated: May 21, 2025

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K
Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.5K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

738

Area of Science:

  • Hematology
  • Cell Biology
  • Immunology

Background:

  • Platelets are vital blood cells involved in hemostasis and immunity.
  • Platelet production involves hematopoietic stem cells differentiating into megakaryocytes, releasing proplatelets that mature in circulation.
  • Disorders of platelet quantity arise from complex regulatory factors impacting production, clearance, and distribution.

Purpose of the Study:

  • To review the intricate regulation of platelet production.
  • To summarize common platelet quantity disorders: thrombocytopenia and thrombocytosis.
  • To consolidate clinical evidence on medication strategies for diverse platelet disorders.

Main Methods:

  • Literature review of scientific studies on platelet production and disorders.
  • Analysis of clinical data concerning thrombocytopenia and thrombocytosis.
  • Synthesis of information on therapeutic interventions for platelet dysregulation.

Main Results:

  • Detailed examination of the multi-step process of platelet biogenesis.
  • Classification and description of conditions leading to low (thrombocytopenia) or high (thrombocytosis) platelet counts.
  • Overview of current pharmacological approaches tailored to specific platelet disorder contexts.

Conclusions:

  • Platelet production is a tightly regulated process susceptible to various disruptions.
  • Thrombocytopenia and thrombocytosis represent significant clinical challenges with diverse etiologies.
  • Effective management of platelet disorders necessitates understanding underlying mechanisms and applying evidence-based treatment strategies.